First Trust Advisors
IBB icon

First Trust Advisors’s iShares Biotechnology ETF IBB Stock Holding History

First Trust Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,186
Closed -$1.67M – 2566
2021
Q2 		$1.67M Sell
10,186
-4,164
-29% -$641K ﹤0.01% 1873
2021
Q1 		$2.16M Buy
14,350
+221
+2% +$35.1K ﹤0.01% 1696
2020
Q4 		$2.14M Buy
14,129
+902
+7% +$129K ﹤0.01% 1540
2020
Q3 		$1.79M Sell
13,227
-951
-7% -$129K ﹤0.01% 1414
2020
Q2 		$1.94M Sell
14,178
-1,314
-8% -$168K ﹤0.01% 1399
2020
Q1 		$1.67M Sell
15,492
-964
-6% -$111K ﹤0.01% 1362
2019
Q4 		$1.98M Buy
16,456
+275
+2% +$30.7K ﹤0.01% 1559
2019
Q3 		$1.61M Buy
16,181
+23
+0.1% +$2.41K ﹤0.01% 1662
2019
Q2 		$1.76M Sell
16,158
-259
-2% -$27.5K ﹤0.01% 1623
2019
Q1 		$1.83M Buy
16,417
+6,701
+69% +$735K ﹤0.01% 1595
2018
Q4 		$937K Sell
9,716
-536
-5% -$56.9K ﹤0.01% 1855
2018
Q3 		$1.25M Sell
10,252
-281
-3% -$33.1K ﹤0.01% 1874
2018
Q2 		$1.16M Sell
10,533
-322
-3% -$34.4K ﹤0.01% 1885
2018
Q1 		$1.16M Buy
10,855
+441
+4% +$48.9K ﹤0.01% 1733
2017
Q4 		$1.11M Buy
10,414
+301
+3% +$32.2K ﹤0.01% 1814
2017
Q3 		$1.13M Sell
10,113
-165
-2% -$17.6K ﹤0.01% 1804
2017
Q2 		$1.06M Buy
10,278
+54
+0.5% +$5.32K ﹤0.01% 1818
2017
Q1 		$999K Buy
10,224
+1,074
+12% +$103K ﹤0.01% 1855
2016
Q4 		$809K Buy
9,150
+171
+2% +$15.6K ﹤0.01% 1927
2016
Q3 		$866K Sell
8,979
-648
-7% -$61.6K ﹤0.01% 1785
2016
Q2 		$826K Buy
+9,627
New +$864K ﹤0.01% 1789
2016
Q1 		– Sell
-6,207
Closed -$700K – 2245
2015
Q4 		$700K Buy
6,207
+75
+1% +$8.14K ﹤0.01% 1868
2015
Q3 		$620K Sell
6,132
-135
-2% -$16.2K ﹤0.01% 1904
2015
Q2 		$771K Sell
6,267
-4,191
-40% -$502K ﹤0.01% 1852
2015
Q1 		$1.2M Buy
+10,458
New +$1.15M ﹤0.01% 1691

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

First Trust Advisors's IBB Position: Q3 2021 in Review

First Trust Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2021, closing a stake of 10,186 shares — an estimated $1.67M sold.

First Trust Advisors first reported a position in IBB in Q1 2015 and held it in 25 quarters. The position peaked at $2.16M in Q1 2021. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

  • First Trust Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
  • First Trust Advisors sold 10,186 iShares Biotechnology ETF shares in Q3 2021, an estimated $1.67M.
  • First Trust Advisors first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 25 quarters.
  • First Trust Advisors's iShares Biotechnology ETF position peaked at $2.16M in Q1 2021.
  • 855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.